tizanidine hydrochloride
- Product NDC
- 49884-611
- 11-digit product format
- 498840611
- Labeler code
- 49884
- Product ID
- 49884-611_52a31ce8-f626-4967-99b3-8fadd976b74f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA207199
- Marketing category
- ANDA
- Marketing start
- 2017-03-15
- Marketing end
- 2022-05-31
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 49884-611-53 | 49884061153 | 150 CAPSULE in 1 BOTTLE (49884-611-53) | 150 capsule | 2017-03-15 | 2022-05-31 | No | No | Current |